Deep clinical expertise in immunology or hematology
Proven track record closing late-stage deals
The role involves leading strategic sourcing and evaluation of later-stage external Hematology therapeutic area opportunities from Phase 2 through marketed drugs
Job Summary
The role involves leading strategic sourcing and evaluation of later-stage external Hematology therapeutic area opportunities from Phase 2 through marketed drugs.
Candidates must possess deep clinical expertise and a proven track record of engaging with external Key Opinion Leaders to validate asset potential.
This hybrid position requires being onsite three days a week at either the Waltham MA or King of Prussia PA office.
Matching Summary
The role involves leading strategic sourcing and evaluation of later-stage external Hematology therapeutic area opportunities from Phase 2 through marketed drugs.
Salary
Base: $263,000 - $328,000; Bonus/Equity: Incentive compensation and equity included; Benefits: Not specified
Skills & Requirements
Must-have
15+ years biopharma experience
Deep clinical expertise in Immunology or Hematology
Proven track record closing late-stage deals
Advanced degree MD or PhD required
Strong understanding of regulatory pathways
Nice-to-have
Experience engaging with Key Opinion Leaders
Knowledge of evolving standards of care
Ability to thrive in agile team environments
Strategic portfolio planning skills
Key Requirements
15+ years in biopharma
MD, PhD, or equivalent advanced degree
Clinical expertise in Immunology, Hematology, or Cardiovascular/Renal
Experience in business development and external innovation